Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6522
    +0.0022 (+0.34%)
     
  • OIL

    82.94
    +0.13 (+0.16%)
     
  • GOLD

    2,332.70
    -5.70 (-0.24%)
     
  • Bitcoin AUD

    98,559.51
    -3,852.59 (-3.76%)
     
  • CMC Crypto 200

    1,389.18
    +6.60 (+0.48%)
     
  • AUD/EUR

    0.6080
    +0.0010 (+0.16%)
     
  • AUD/NZD

    1.0952
    +0.0010 (+0.09%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,270.54
    +69.27 (+0.40%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

What Are Teva Pharmaceutical’s Key Growth Drivers in 2019?

What Are Teva Pharmaceutical’s Key Growth Drivers in 2019?

Is Teva Pharmaceutical an Attractive Pick This February?(Continued from Prior Part)Growth driversOn its fourth-quarter earnings conference call, Teva Pharmaceutical (TEVA) highlighted Ajovy and Austedo as its key growth drivers for 2019.Copaxone